Whitehawk Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Whitehawk Therapeutics, Inc. (WHWK) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents28.6762.8939.02148.994.46
Short-Term Investments18.5745.96133.540.000.00
Cash & Short-Term Investments47.24108.85172.56148.994.46
Accounts Receivable5.905.491.860.0014.15
Inventory5.316.431.860.000.00
Other Current Assets2.843.833.752.670.08
Total Current Assets61.29124.59180.03151.2718.69
Non-Current Assets
Property, Plant & Equipment (Net)7.635.972.030.610.14
Intangible Assets0.000.000.003.810.00
Other Non-Current Assets1.401.872.182.210.00
Total Non-Current Assets9.037.844.216.640.00
Total Assets70.32132.42184.24157.9118.83
Current Liabilities
Accounts Payable2.165.903.5215.142.39
Short-Term Debt0.270.000.000.009.03
Current Portion of Long-Term Debt0.000.000.000.009.03
Accrued Liabilities14.5814.319.467.246.90
Other Current Liabilities14.655.761.900.2611.61
Total Current Liabilities17.0726.4018.8415.2730.06
Non-Current Liabilities
Long-Term Debt0.570.831.270.471.10
Other Non-Current Liabilities0.205.765.765.760.10
Total Non-Current Liabilities0.776.597.026.230.00
Total Liabilities17.8427.2325.8621.5031.26
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-332.65-268.96-203.20-142.69-32.60
Accumulated Other Comprehensive Income0.020.03-0.120.000.00
Additional Paid-in Capital385.11374.13361.69279.090.00
Shares Outstanding24.6824.5524.4420.890.00
Total Stockholders' Equity52.48105.20158.38136.41-12.43
Total Liabilities & Equity70.32132.42184.24157.910.00